96 related articles for article (PubMed ID: 213186)
1. A stratified randomized study of intradermal BCG in patients with carcinoma of the bronchus: prolongation of quality but not length of life in inoperable patients.
Anthony HM; Madsen KE; Mason MK; Templeman GH
Cancer; 1978 Oct; 42(4):1784-92. PubMed ID: 213186
[TBL] [Abstract][Full Text] [Related]
2. Trial of BCG immunotherapy in the treatment of resectable sequamous cell carcinoma of the bronchus (stages I and II).
Pouillart P; Mathé G; Palangie T; Schwarzenberg L; Huguenin P; Morin P; Gautier H; Baron A
Recent Results Cancer Res; 1977; (62):151-5. PubMed ID: 341247
[No Abstract] [Full Text] [Related]
3. The prognostic significance of DHS skin tests in patients with carcinoma of bronchus.
Anthony HM; Templeman GH; Madsen KE; Mason MK
Cancer; 1974 Dec; 34(6):1901-6. PubMed ID: 4373163
[No Abstract] [Full Text] [Related]
4. Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).
Jansen HM; The TH; de Gast GC; Esselink MT; van der Wal AM; Orie NG
Thorax; 1978 Aug; 33(4):429-38. PubMed ID: 358479
[No Abstract] [Full Text] [Related]
5. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
Jansen HM; The TH; Orie NG
Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
[TBL] [Abstract][Full Text] [Related]
6. Attempt at immunotherapy with living BCG in patients with bronchus carcinoma.
Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G
Recent Results Cancer Res; 1978; 68():260-7. PubMed ID: 752864
[No Abstract] [Full Text] [Related]
7. E and EAC rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: effect of BCG.
Anthony HM; Kirk JA; Madsen KE; Mason MK; Templeman GH
Clin Exp Immunol; 1975 Apr; 20(1):41-54. PubMed ID: 54235
[TBL] [Abstract][Full Text] [Related]
8. BCG plus levamisole following irradiation of advanced squamous bronchial carcinoma.
Pines A
Int J Radiat Oncol Biol Phys; 1980 Aug; 6(8):1041-2. PubMed ID: 7419462
[No Abstract] [Full Text] [Related]
9. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
10. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
11. Immune status in lung cancer: effects of BCG immunotherapy.
Gross NJ; Eddie-Quartey AC
Am Rev Respir Dis; 1976 Apr; 113(4):457-64. PubMed ID: 178255
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy as an adjuvant to surgery in carcinoma of bronchus. Results in three randomised trials.
Roeslin N; Dumont P; Morand G; Wihlm JM; Witz JP
Eur J Cardiothorac Surg; 1989; 3(5):430-5. PubMed ID: 2483977
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
Warren SE; Crispen RG; Nika B
Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
[TBL] [Abstract][Full Text] [Related]
14. [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].
Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G; Lededente A; Botto G
Nouv Presse Med; 1978 Jan; 7(4):265-9. PubMed ID: 345229
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
[TBL] [Abstract][Full Text] [Related]
16. Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma.
Law MR; Lam WK; Studdy PR; Pugsley WB; Hodson ME
Br J Dis Chest; 1982 Apr; 76(2):151-6. PubMed ID: 7093133
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
Yamamura Y; Sakatani M; Ogura T; Azuma I
Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized BCG (Tice strain) treatment of bronchogenic carcinoma: phase I study.
Cusumano CL; Jernigan JA; Waldman RH
J Natl Cancer Inst; 1975 Aug; 55(2):275-9. PubMed ID: 169370
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity in operable bronchial carcinoma: the effect of injecting irradiated autologous tumour cells and BCG.
Stack BH; McSwan N; Stirling JM; Hole DJ; Parratt D; Spilg WG; Gillis CR; McHattie I; Green AG; White RG; Turner MA
Thorax; 1979 Feb; 34(1):68-73. PubMed ID: 442002
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis of inoperable bronchial carcinoma].
Lutomirsky C; Brunner KW
Schweiz Med Wochenschr; 1974 May; 104(21):760-7. PubMed ID: 4133481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
